Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

March 8, 2024 admin-dominor

[ad_1]

Wegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday after fresh early trial data showed positive results for its new experimental weight loss pill.

[ad_2]

Source link

Israeli army chief orders ‘plans for a ground operation’ in Lebanon: Report
A plan to bring down drug prices could threaten America’s technology boom

You May Also Like

Robocalling is already an issue for Americans. AI is making it worse

Antarctic penguin turns up in New Zealand after swimming nearly 2,000 miles off course

Soccer star Son Heung-min gives his top 3 tips for making it as a pro athlete